Hubei Key Laboratory of Resources and Chemistry of Chinese Medicine, School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
Infinitus (China) Company Ltd, Guangzhou 510623 China.
J Pharm Biomed Anal. 2022 Jan 5;207:114422. doi: 10.1016/j.jpba.2021.114422. Epub 2021 Oct 8.
Morinda officinalis, a well-known traditional herbal medicine in China, is used to treat deficiency of kidney-yang syndrome. Although this medicine has the property of "reinforcing kidney to strengthening Yang," the chemical constituents responsible for this effect remain to be elucidated. Here, we aimed to identify the main active compounds responsible for reinforcing kidney to strengthening Yang, based on spectrum-effect relationships combined with chemometrics. We used the UPLC-diode array detection method to establish the chromatography fingerprint of M. officinalis. Hydrocortisone-induced and adenine-induced kidney-yang deficiency patterns were established to evaluate the efficacy of M. officinalis. Serum triiodothyronine, free thyroxine, thyrotropin, testosterone, cortisol, luteinizing hormone, follicle-stimulating hormone, corticotropin-releasing hormone, and adrenocorticotropic hormone levels were determined as pharmacodynamic indices. Analytic hierarchy process was used to determine the weight of each index to the total pharmacodynamic contribution. Lastly, the spectrum-effect between the fingerprint and the pharmacological effects were established using grey relational analysis and partial least squares. Our findings indicated that peaks 1, 2, 3, 5, 6, 7, 8, 9, 11, 13, 15, 17, and 20 might represent the main components that positively correlated to the total effect, of which four were identified by comparison with reference standards. The identified components were monotropein (peak 1), deacetyl asperulosidic acid (peak 3), asperulosidic acid (peak 8), and asperuloside (peak 9). Our results suggest that the "reinforce kidney to strengthening Yang" effects were attributable to the combined effects of the multiple chemical components of M. officinalis and provide a valuable method to identify the active "reinforce kidney to strengthening Yang" components of M. officinalis and establish the quality control of M. officinalis.
巴戟天是中国著名的传统草药,用于治疗肾阳虚证。虽然这种药物具有“补肾壮阳”的特性,但负责这种效果的化学成分仍有待阐明。在这里,我们旨在基于谱效关系结合化学计量学,鉴定负责补肾壮阳的主要活性化合物。我们使用 UPLC-二极管阵列检测方法建立了巴戟天的色谱指纹图谱。建立氢化可的松诱导和腺嘌呤诱导的肾阳虚模型,以评价巴戟天的功效。测定血清三碘甲状腺原氨酸、游离甲状腺素、促甲状腺素、睾酮、皮质醇、黄体生成素、卵泡刺激素、促肾上腺皮质激素释放激素和促肾上腺皮质激素水平作为药效学指标。用层次分析法确定每个指标对总药效贡献的权重。最后,采用灰色关联分析和偏最小二乘法建立指纹图谱与药理作用之间的谱效关系。研究结果表明,峰 1、2、3、5、6、7、8、9、11、13、15、17 和 20 可能代表与总效应呈正相关的主要成分,其中四个通过与对照品比较鉴定。鉴定出的成分是莫诺苯宗(峰 1)、去乙酰asperulosidic 酸(峰 3)、asperulosidic 酸(峰 8)和asperuloside(峰 9)。研究结果表明,“补肾壮阳”作用归因于巴戟天多种化学成分的综合作用,为鉴定巴戟天“补肾壮阳”活性成分和建立巴戟天质量控制提供了有价值的方法。